UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000010795
Receipt No. R000012607
Official scientific title of the study Usefulness of a navigation system "Directpath" in bronchoscopy for pulmonary peripheral lesions
Date of disclosure of the study information 2013/05/23
Last modified on 2018/06/20 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Usefulness of a navigation system "Directpath" in bronchoscopy for pulmonary peripheral lesions
Title of the study (Brief title) Usefulness of a navigation system "Directpath" in bronchoscopy for pulmonary peripheral lesions
Region
Japan

Condition
Condition Benign or malignant pulmonary lesions
Classification by specialty
Pneumology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate the usefulness of the navigation system Directpath in bronchoscopy for pulmonary peripheral lesions.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Not applicable

Assessment
Primary outcomes Diagnostic yield
Key secondary outcomes Directpath
The bronchial generation order allowing automatic virtual image production
The bronchial generation order for which manual registration is added

Bronchoscope
Consistency with virtual images
The bronchial generation order allowing insertion and the outer diameter of the bronchus on virtual images
The distance from the bronchoscope insertion site to the lesion and the number of bronchial divisions
The bronchial generation order allowing observation
The bronchial generation order allowing observation

Diagnostic yield
Diagnostic yields according to the method and bronchoscope used
Diagnostic yield according to the lesion size
Diagnostic yields according to the distance between the lesion and hilum
Diagnosis yields according to the lesion visualization rate using ultrasound, whether the lesion is visualized, and the positional relationship between the ultrasound probe and lesion Visibility on EBUS.
Diagnostic yield according to location of probe in relation to target lesion

Examination time

Safety, Complications

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Diagnosis
Type of intervention
Device,equipment
Interventions/Control_1 Virtual images toward pulmonary peripheral lesions are produced using Directpath.
Transbronchial biopsy (TBB) with virtual bronchoscopic navigation (VBN) is performed using a 2.8-mm ultrathin bronchoscope (BF-XP260F; channel inner diameter, 1.2 mm; Olympus). Subsequently, endobronchial ultrasound-guided transbronchial biopsy (EBUS-TBB) /transbronchial needle aspiration (TBNA) with VBN is performed using a 4.0-mm bronchoscope (BF-P260F, inner diameter of the operation channel, 2.0 mm; Olympus).
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1. On chest CT images, an abnormal shadow is present in the peripheral area of the lung field, and bronchoscopy is necessary to make a diagnosis or determine treatment principles
2. 20 years of age or older
3. Consent in writing to participate in this study has been obtained from patients themselves
Key exclusion criteria 1. Case with serious concomitant medical illness
2. Central pulmonary lesions
3. Diffuse pulmonary lesions
4. Re-examination due to prior failure in this trial
5. Case with pure ground glass opacity
6. Patients needing to undergo other bronchoscopic procedures (e.g. TBNA, BAL)
7. Bleeding tendency
8. Pregnant woman
9. Other clinical difficulties in this trial
Target sample size 30

Research contact person
Name of lead principal investigator Fumihiro Asano
Organization Gifu Prefectural General Medical Center
Division name Department of Pulmonary Medicine and Bronchoscopy
Address 4-6-1, Noishiki, Gifu, Japan
TEL 058-246-1111
Email

Public contact
Name of contact person Akifumi Tsuzuku
Organization Gifu Prefectural General Medical Center
Division name Department of Pulmonary Medicine and Bronchoscopy
Address 4-6-1, Noishiki, Gifu, Japan
TEL 058-246-1111
Homepage URL
Email a.tsuzuku@gmail.com

Sponsor
Institute Gifu Prefectural General Medical Center
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 岐阜県総合医療センター(岐阜県)

Other administrative information
Date of disclosure of the study information
2013 Year 05 Month 23 Day

Progress
Recruitment status Completed
Date of protocol fixation
2013 Year 05 Month 23 Day
Anticipated trial start date
2013 Year 05 Month 23 Day
Last follow-up date
2013 Year 11 Month 30 Day
Date of closure to data entry
2013 Year 12 Month 31 Day
Date trial data considered complete
2013 Year 12 Month 31 Day
Date analysis concluded
2014 Year 05 Month 31 Day

Related information
URL releasing protocol
Publication of results Published
URL releasing results
Results
Other related information

Management information
Registered date
2013 Year 05 Month 23 Day
Last modified on
2018 Year 06 Month 20 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012607